Cellares locks in $82m Series B
Cellares Corporation, a life sciences technology company, has secured $82 million in Series B funding.
Cellares Corporation, a life sciences technology company, has secured $82 million in Series B funding.
Copyright PEI Media
Not for publication, email or dissemination